Stopped: COVID-19 placed all Charleston VA projects on hold. Recently gained approval to open studies with COVID-19 precautions
Despite the availability of opioid replacement therapies, many opioid use disordered Veterans are not able to remain abstinent. Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive neuromodulation technique with a consistent, rapidly expanding literature base reporting positive outcomes in substance using populations. This pilot application will investigate a novel multi-session rTMS paradigm to determine feasibility and tolerability of this intervention in opioid use disordered Veterans.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Retention: Total Number of rTMS Sessions Completed
Timeframe: Through study completion, an average of 3 weeks
Tolerability: The Total Number of Treatment Emergent Adverse Events
Timeframe: Through study completion, an average of 3 weeks